Atlas Trials

Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Clinical trial NCT04309136 · UNKNOWN

Trial details

NCT number
NCT04309136
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2019-06-01
Primary completion
2021-02-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.